General information
eleva GmbH
Hans-Bunte-Str. 19
79108 Freiburg, Baden-Württemberg
Germany
Contact person: Jana Gross, Director Business Development
Company main phone: +49 (761) 470990
Company main fax: +49 (761) 47099191
Website: https://www.elevabiologics.com
Year founded: | 1999
|
Source of foundation: | Independent foundation |
No. of employees: |
Worldwide: 30 |
Corporate description / mission:
eleva GmbH develops biological therapies with its pharmaceutical partners. The privately-held company leverages its unique moss-based production platform to produce antibodies, replacement enzymes, and fusion toxins. Eleva has successfully developed drug candidates into clinical phases.
State of ownership: Private / independent
Headquarters: HQ: Yes
Categorization
Sector: |
- Biotechnology - Therapeutics and Diagnostics
|
Subsector: |
- Antibodies
- Antibody-drug-conjugate
- Proteins
|
Primary therapeutic areas: |
- Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
- Endocrine, nutritional and metabolic diseases / endocrinology
- Genitourinary system / Urology
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
|
Business model: |
- Out-licensing
- R&D
- Research on contract basis
|
Customer segments: |
- Large biotech & big pharma
- Small biotech
|
Summary Products / Services / Technologies
Number of Biotech Products
Description of products:
Compleva FH /CPV-104
Compleva MFHR1/CPV-102
Repleva AGAL/RPV-001, etc.